Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409120 · ClinicalTrials.gov registry record · NA
Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
A NA study of Parkinson Disease and Dystonia-Parkinsonism, Adult-Onset, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03409120 is a NA study of Parkinson Disease and Dystonia-Parkinsonism, Adult-Onset that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 38 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03409120, a NA study of Parkinson Disease and Dystonia-Parkinsonism, Adult-Onset, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study occurs during five visits that are already scheduled as part of "Biomarkers to Guide Directional DBS for Parkinson's Disease" (ClinicalTrials.gov Identifier: NCT03353688). If participants have dystonia associated with Parkinson's disease, the investigators will consent and administer one additional rating scale (Burke-Fahn-Marsden Dystonia Rating Scale) to assess the severity of dystonia.
Conditions Studied
Interventions
- DEVICE Boston Scientific Vercise PC IPG with directional DBS lead
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409120
The ClinicalTrials.gov registry entry for NCT03409120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific Vercise PC IPG with directional DBS lead is the first listed.
NCT03409120 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03409120 about?
NCT03409120 is a clinical study titled "Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology". This study occurs during five visits that are already scheduled as part of "Biomarkers to Guide Directional DBS for Parkinson's Disease" (ClinicalTrials.gov Identifier: NCT03353688). If participants have dystonia associated with Parkinson's disease, the investigators will consent and administer one ...
What is the current status of trial NCT03409120?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2018-01-01. Estimated completion is 2022-06-30.
What conditions does trial NCT03409120 study?
This clinical trial studies the following conditions: Parkinson Disease, Dystonia-Parkinsonism, Adult-Onset.
What interventions are being tested in trial NCT03409120?
The interventions under investigation include: Boston Scientific Vercise PC IPG with directional DBS lead (DEVICE).
Who is sponsoring clinical trial NCT03409120?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409120 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.